Notably, expression levels of the m6A methyltransferases METTL3 and METTL14 in CML cell lines are comparable if not higher, as in the case of K562 cells, than that of AML cell lines (Fig. 1A). The gene discussed is METTL3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.